Blockade of the TLR4–MD2 complex lowers blood pressure and improves vascular function in a murine model of type 1 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of the TLR4–MD2 complex lowers blood pressure and improves vascular function in a murine model of type 1 diabetes
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-21
DOI
10.1038/s41598-020-68919-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin‐angiotensin system in mouse kidneys
- (2019) Yi Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Toll-Like Receptor 4 and Blood Pressure: Lessons From Animal Studies
- (2019) Kenia Pedrosa Nunes et al. Frontiers in Physiology
- Macrovasculature and Microvasculature at the Crossroads Between Type 2 Diabetes Mellitus and Hypertension
- (2019) Rachel E. Climie et al. HYPERTENSION
- Unveiling the Interplay between the TLR4/MD2 Complex and HSP70 in the Human Cardiovascular System: A Computational Approach
- (2019) Amanda Almeida de Oliveira et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting TLR4 signaling pathways: can therapeutics pay the toll for hypertension?
- (2018) Kenia Pedrosa Nunes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Toll-Like Receptor 4 and Heat-Shock Protein 70: is it a New Target Pathway for Diabetic Vasculopathies?
- (2018) Amanda Almeida de Oliveira et al. CURRENT DRUG TARGETS
- Mechanistic Insights into High Mobility Group Box-1 (HMGb1) induced Toll-like Receptor 4 (TLR4) Dimer Formation
- (2018) Shan Sun et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Blockade of Toll-Like Receptor 4 Attenuates Erectile Dysfunction in Diabetic Rats
- (2018) Kenia Pedrosa Nunes et al. Journal of Sexual Medicine
- Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway
- (2018) Bin Leng et al. LIFE SCIENCES
- Vascular Oxidative Stress: Impact and Therapeutic Approaches
- (2018) Cristina M. Sena et al. Frontiers in Physiology
- The immunology of hypertension
- (2017) Allison E. Norlander et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction
- (2017) Kenia P. Nunes et al. LIFE SCIENCES
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
- (2017) Yan Zheng et al. Nature Reviews Endocrinology
- MD2 Blockage Protects Obesity-Induced Vascular Remodeling via Activating AMPK/Nrf2
- (2017) Lintao Wang et al. Obesity
- The interplay between Angiotensin II, TLR4 and hypertension
- (2017) Vinicia Campana Biancardi et al. PHARMACOLOGICAL RESEARCH
- Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
- (2017) Zheng Xu et al. Scientific Reports
- Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney
- (2017) Sathnur Pushpakumar et al. Scientific Reports
- MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway
- (2016) Jibo Han et al. BASIC RESEARCH IN CARDIOLOGY
- Post-Translational Modification Control of Innate Immunity
- (2016) Juan Liu et al. IMMUNITY
- Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
- (2015) R Hernanz et al. BRITISH JOURNAL OF PHARMACOLOGY
- TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase
- (2015) Tadaaki Nakashima et al. HYPERTENSION RESEARCH
- Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4
- (2015) Susumu Matsuda et al. Journal of Atherosclerosis and Thrombosis
- Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats
- (2015) Maria Alicia Carrillo-Sepulveda et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats
- (2015) G.F. Bomfim et al. LIFE SCIENCES
- Type 1 Diabetes Mellitus and Cardiovascular Disease
- (2014) Sarah D. de Ferranti et al. CIRCULATION
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- NADPH Oxidases in Vascular Pathology
- (2013) Anna Konior et al. ANTIOXIDANTS & REDOX SIGNALING
- 1,25(OH)2D3-Mediated Amelioration of Aortic Injury in Streptozotocin-Induced Diabetic Rats
- (2013) Fengao Li et al. INFLAMMATION
- The Immune System: Role in Hypertension
- (2012) Ernesto L. Schiffrin CANADIAN JOURNAL OF CARDIOLOGY
- Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
- (2012) Katrin Schröder et al. CIRCULATION RESEARCH
- Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats
- (2012) Gisele F. Bomfim et al. CLINICAL SCIENCE
- The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications
- (2012) Ishwarlal Jialal et al. Current Diabetes Reports
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- NOX5, a New “Radical” Player in Human Atherosclerosis?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2008) Eberhard Schulz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started